Contamination Detection in NGS: Methods, Controls & QC Protocol
DNA extraction reagent contamination is one of the most serious yet underappreciated threats to accurate metagenomic next-generation sequencing (mNGS) results — and one of the hardest to eliminate. Reliable contamination detection in NGS depends on understanding where reagent-derived microflora enters the workflow and how to distinguish it from true pathogen signal. While surface contamination and environmental sources receive considerable attention, the microflora inherent in extraction kits themselves can introduce false-positive signals that mimic real pathogens, triggering misidentification and costly retesting. Eliminating cross-contamination in NGS therefore requires controls that capture the reagent background, not just the laboratory environment. In a micro-webinar featuring research conducted at the China Medical University Hospital (CMUH) in Taiwan, Dr. Maurice Chan and Dr. Zi-Lun Lai presented systematic data comparing contamination profiles across extraction reagent brands, lots, and laboratory sites.
Key Takeaways
- Every extraction reagent brand tested carried a distinct contaminating microflora profile, confirming that most background organisms originate from the reagents themselves
- Contaminant profiles vary significantly between lots of the same brand, making lot-specific negative controls essential
- Spike-in process controls (SICP) serve as both positive and negative controls without introducing additional contaminants
- A consistent blood microbiome was not detected in 10 healthy controls, eliminating the need for healthy blood as a negative control
- Purpose-built bioinformatics filtering reduced raw organism calls from hundreds to two confirmed pathogens in a clinical sample
- Lot-matched negative controls and SICP spike-ins are the most effective way to eliminate cross-contamination in NGS workflows that use commercial extraction kits
Where Reagent Contamination Enters the mNGS Workflow
Contamination can enter at virtually every stage of the mNGS workflow: sample acquisition (skin microflora during blood draws), DNA extraction (reagent-inherent microflora), library preparation (reagent contamination and barcode hopping), and sequencing (alignment errors caused by conserved microbial sequences). However, research has increasingly identified extraction reagents as the most serious contamination source.
Published studies have traced organisms long assumed to be disease-associated back to spin column microflora. For example, Parvovirus sequences associated with certain diseases were ultimately found to originate from extraction column contamination. These findings underscore that reagent contamination does not merely add noise — it can generate clinically misleading signals.
Despite growing awareness, no established criteria exist for identifying or excluding contaminants from extraction reagents, and manufacturers of extraction kits generally do not guarantee the absence of contaminating DNA in their products.
Brand-to-Brand Variation in Extraction Kit Microflora
The CMUH study compared extraction reagents from multiple brands (designated M, Q, R, and Z) using two types of input material: molecular biology grade (MBG) water (representing an extraction blank) and a spike-in process control (SICP) containing two known organisms, Allobacillus halotolerans and Imtechella halotolerans.
Heat map and principal component analysis (PCA) clustering revealed that each brand carried a distinct contaminant profile. The backgrounds were non-overlapping between brands, confirming that the organisms were inherent to the reagents rather than introduced from a shared environmental source.
Critically, MBG water and SICP samples produced indistinguishable contamination profiles within each brand, demonstrating that the spike-in control organisms did not introduce additional contaminants. This finding validates SICP as a dual-purpose control: positive (the two spike-in organisms should be detected) and negative (all other organisms represent reagent background).
Among the brands tested, Devin Microbial Enrichment Kit reagents showed the lowest background contamination, appearing predominantly as dark blue (low frequency) on the heat map while other brands displayed large blocks of red and light blue (high frequency) for numerous organisms.
Lot-to-Lot Inconsistency Within the Same Brand
The study also examined multiple lots from the same brand and found that contaminant profiles varied substantially between lots. This has direct operational implications: a negative control processed with a different reagent lot than the test sample may fail to capture the relevant background organisms, leading to incorrect pathogen calls.
The practical recommendation is straightforward. Negative controls must come from the same reagent lot as the test samples and should be processed simultaneously. Manufacturers should provide lot-specific quality control certificates documenting the background microflora for each reagent lot.
Cross-Site Reproducibility of Contaminant Profiles
To determine whether contaminant profiles are site-dependent, the study compared results from reagents quality-controlled at the Micronbrane Medical laboratory and then used at CMUH. The heat maps showed largely consistent profiles between sites, with only sporadic environmental contamination events appearing at the CMUH laboratory.
This cross-site consistency means that the manufacturer’s QC certificate for reagent background is broadly applicable regardless of where the reagents are used. However, each laboratory should still run its own negative controls to capture any site-specific environmental contamination.
Does a Blood Microbiome Complicate Negative Controls?
Earlier publications suggested that healthy blood might harbor a baseline microbiome that would need to be accounted for in negative controls. If true, laboratories would need to maintain healthy blood samples as control material, creating significant logistical burden.
The CMUH study tested 10 healthy blood controls against extraction blanks and found no consistent microflora. None of the healthy controls produced significant organism calls. This eliminates the need for healthy blood as negative control material. Standard extraction blanks, MBG water, or SICP controls are sufficient for background subtraction.
Contamination Detection in NGS: Filtering Hundreds of Hits to True Pathogens
The webinar demonstrated the critical role of bioinformatics filtering using data from an endometrial sample. Raw sequencing produced hundreds of organism hits. Applying a minimum threshold of 10 reads still yielded 129 organisms. Filtering by microbial sequence percentage (at least 0.1% of total microbial reads) reduced the list to 39. Applying system control subtraction (comparing against the negative control) brought the count to 11. Final computational filtering identified just two confirmed pathogens.
PaRTI-Seq Analysis implements this multi-stage filtering approach automatically. The platform uses a curated database of over 1,400 pathogens and applies system control subtraction followed by fold-change thresholds to distinguish true signal from reagent background. The final report includes genome coverage uniformity plots, allowing the interpreting clinician to verify that the identified organism’s genome was uniformly sequenced, as expected for whole-genome mNGS.
Contamination QC Checklist for NGS Laboratories
The CMUH research distills into a set of practical QC steps that any laboratory running mNGS can implement regardless of which extraction kit they use. Each item maps directly to one of the contamination failure modes described above.
- Use lot-matched negative controls. Process a negative control (MBG water or extraction blank) from the same reagent lot as your test samples, in the same run. A negative control from a different lot will not capture the relevant lot-specific background organisms and may miss real contamination.
- Add a spike-in process control (SICP). Include SICP organisms (Allobacillus halotolerans and Imtechella halotolerans, or equivalent) in every sample including the no-template control. SICP serves simultaneously as a positive control (confirming the spike-in organisms are recovered) and a negative control (all other organisms represent reagent background). It adds no new contamination of its own.
- Apply system control subtraction before pathogen calling. Cross-reference all organism calls against the matched negative control. Only organisms present in the sample at a read count significantly above the negative control background should advance to pathogen-calling. Raw hit lists without this subtraction step will contain dozens of reagent-origin organisms.
- Request lot-specific QC certificates from your reagent supplier. The CMUH data show that manufacturers’ background profiles are broadly reproducible across sites, so a manufacturer-provided lot certificate is meaningful — but only if it is lot-specific, not a generic product-level statement.
- Verify genome coverage uniformity on final pathogen calls. A high read count mapping to a narrow genomic region may indicate misclassification rather than true detection. Coverage uniformity plots confirm that reads span the organism’s genome broadly, as expected for whole-genome sequencing of a genuine sample constituent.
Applying all five steps addresses the reagent contamination QC problem end to end: lot-matched controls prevent false negatives in the control comparison, SICP provides a built-in positive/negative standard, system control subtraction eliminates reagent background from the final call list, lot certificates extend QC accountability to the manufacturer, and coverage verification catches any residual misclassification. For broader context on contamination sources and mNGS standards, see Why mNGS Standards Matter for Microbiome Analysis and Removing Surface Contamination.
About the Speakers
Dr. Maurice Chan is the RD Lead at Micronbrane Medical. He has a distinguished record of developing high-value, high-complexity NGS-based diagnostic assays, with prior roles at MiRXES, Angsana Molecular & Diagnostics, Changi General Hospital, the National Cancer Centre Singapore, Vela Diagnostics, and the U.S. Centers for Disease Control and Prevention. He earned his bachelor’s, master’s, and doctorate in microbiology and molecular biology at the National University of Singapore.
Dr. Zi-Lun Lai is a post-doctoral research fellow in the Department of Laboratory Medicine at the China Medical University Hospital in Taiwan. She led this research and has over 20 peer-reviewed publications.
